Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation

被引：36

作者：

Montano-Loza, Aldo J. ^{[1
,2
]}

Ronca, Vincenzo ^{[3
,4
,5
]}

Ebadi, Maryam ^{[1
,2
]}

Hansen, Bettina E. ^{[6
]}

Hirschfield, Gideon ^{[6
]}

Elwir, Saleh ^{[7
]}

Alsaed, Mohamad ^{[7
]}

Milkiewicz, Piotr ^{[8
]}

Janik, Maciej K. ^{[8
]}

Marschall, Hanns-Ulrich ^{[9
]}

Burza, Maria Antonella ^{[9
]}

Efe, Cumali ^{[10
]}

Caliskan, Ali Riza ^{[11
]}

Harputluoglu, Murat ^{[11
]}

Kabacam, Gokhan ^{[12
]}

Terrabuio, Debora ^{[13
]}

Onofrio, Fernanda de Quadros ^{[6
]}

Selzner, Nazia ^{[6
]}

Bonder, Alan ^{[14
]}

Pares, Albert ^{[15
]}

Llovet, Laura ^{[15
]}

Akyildiz, Murat ^{[16
,17
]}

Arikan, Cigdem ^{[18
]}

Manns, Michael P. ^{[19
]}

Taubert, Richard ^{[19
]}

Weber, Anna-Lena ^{[19
]}

Schiano, Thomas D. ^{[20
]}

Haydel, Brandy ^{[20
]}

Czubkowski, Piotr ^{[21
]}

Socha, Piotr ^{[21
]}

Oldak, Natalia ^{[21
]}

Akamatsu, Nobuhisa ^{[22
]}

Tanaka, Atsushi ^{[23
]}

Levy, Cynthia ^{[24
]}

Martin, Eric F. ^{[24
]}

Goel, Aparna ^{[25
]}

Sedki, Mai ^{[25
]}

Jankowska, Irena ^{[26
]}

Ikegami, Toru ^{[27
]}

Rodriguez, Maria ^{[28
]}

Sterneck, Martina ^{[28
]}

Weiler-Normann, Christina ^{[28
]}

Schramm, Christoph ^{[28
]}

Donato, Maria Francesca ^{[29
]}

Lohse, Ansgar ^{[30
]}

Andrade, Raul J. ^{[31
,32
]}

Patwardhan, Vilas R. ^{[14
]}

van Hoek, Bart ^{[33
]}

Biewenga, Maaike ^{[33
]}

Kremer, Andreas E. ^{[34
,35
,36
]}

机构：

[1] Univ Alberta, Div Gastroenterol, Edmonton, AB, Canada

[2] Univ Alberta, Liver Unit, Edmonton, AB, Canada

[3] Univ Birmingham, Ctr Liver Res, Birmingham, W Midlands, England

[4] Univ Birmingham, NIHR Birmingham BRC, Birmingham, W Midlands, England

[5] Univ Birmingham, Univ Hosp Birmingham NHS Fdn Trust, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England

[6] Univ Toronto, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada

[7] Baylor Univ, Med Ctr, Dallas, TX USA

[8] Med Univ Warsaw, Liver & Internal Med Unit, Warsaw, Poland

[9] Sahlgrens Univ Hosp, Gothenburg, Sweden

[10] Harran Univ Hosp, Dept Gastroenterol, Sanliurfa, Turkey

[11] Inonu Univ, Dept Gastroenterol, Sch Med, Malatya, Turkey

[12] Guven Hosp Ankara, Clin Gastroenterol & Liver Transplantat, Ankara, Turkey

[13] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil

[14] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA

[15] Univ Barcelona, Hosp Clin, Liver Unit, CIBERehd,IDIBAPS, Barcelona, Spain

[16] Koc Univ, Dept Gastroenterol, Sch Med, Istanbul, Turkey

[17] Koc Univ, Sch Med, Liver Transplantat Ctr, Istanbul, Turkey

[18] Koc Univ, Sch Med Pediat Gastroenterol & Hepatol, Organ Transplantat Ctr, Koc Univ Res Ctr Translat Med KUTTAM, Istanbul, Turkey

[19] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, European Reference Network Hepatol Dis ERN RARE L, Hannover, Germany

[20] Mt Sinai Med Ctr, Div Liver Dis, Recanati Miller Transplantat Inst, New York, NY 10029 USA

[21] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol Nutr Disorders & Pedia, Warsaw, Poland

[22] Univ Tokyo, Tokyo, Japan

[23] Teikyo Univ, Sch Med, Dept Med, Tokyo, Japan

[24] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[25] Stanford Univ, Stanford, CA 94305 USA

[26] Childrens Mem Hlth Inst, Warsaw, Poland

[27] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan

[28] UKE Hamburg, Hamburg, Germany

[29] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Liver Tranplant Hepatol Unit, Div Gastroenterol & Hepatol, Milan, Italy

[30] Univ Med Ctr, Hamburg, Germany

[31] Univ Malaga, Univ Hosp, Gastroenterol Serv IBIMA, Malaga, Spain

[32] Univ Malaga, CIBERehd, Malaga, Spain

[33] Leiden Univ Med Ctr, Leiden, Netherlands

[34] Univ Hosp Erlangen, Dept Med, Erlangen, Germany

[35] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany

[36] Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland

[37] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan

[38] Univ Utah, Salt Lake City, UT USA

[39] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[40] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy

[41] Univ Padua, Padua, Italy

[42] Epatoctr Ticino, Lugano, Switzerland

[43] Univ Svizzera Italiana, Lugano, Switzerland

[44] UPMC Pediat Liver Ctr, Palermo, Italy

[45] IRCCS Bambino Gesu Pediat Hosp, Hepatogastroenterol Nutr & Liver Transplant, Rome, Italy

[46] Henry Ford Hlth Syst, Detroit, MI USA

[47] Univ Paris, Hop Necker, Pediat Liver Unit, French Natl Reference Ctr Rare Dis BA & Genet Cho, Paris, France

[48] Hop Necker Enfants Malad, Gastroenterol Hepatol Nutr Unit, Paris, France

[49] Kings Coll Hosp NHS Fdn Trust, London, England

[50] Univ Birmingham, Ctr Liver & Gastro Res, Birmingham, W Midlands, England

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷 / 01期

基金：

加拿大健康研究院;

关键词：

autoimmune liver disease; recurrent disease; survival; graft survival; liver transplantation; PRIMARY BILIARY-CIRRHOSIS; CYCLOSPORINE; SURVIVAL; DISEASE; DIAGNOSIS; MODEL;

D O I：

10.1016/j.jhep.2022.01.022

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background & Aims: Autoimmune hepatitis can recur after liver transplantation (LT), though the impact of recurrence on patient and graft survival has not been well characterized. We evaluated a large, international, multicenter cohort to identify the probability and risk factors associated with recurrent AIH and the association between recurrent disease and patient and graft survival. Methods: We included 736 patients (77% female, mean age 42 +/- 1 years) with AIH who underwent LT from January 1987 through June 2020, among 33 centers in North America, South America, Europe and Asia. Clinical data before and after LT, biochemical data within the first 12 months after LT, and immunosuppression after LT were analyzed to identify patients at higher risk of AIH recurrence based on histological diagnosis. Results: AIH recurred in 20% of patients after 5 years and 31% after 10 years. Age at LT <= 42 years (hazard ratio [HR] 3.15; 95% CI 1.22-8.16; p = 0.02), use of mycophenolate mofetil post-LT (HR 3.06; 95% CI 1.39-6.73; p = 0.005), donor and recipient sex mismatch (HR 2.57; 95% CI 1.39-4.76; p = 0.003) and high IgG pre-LT (HR 1.04; 95% CI 1.01-1.06; p = 0.004) were associated with higher risk of AIH recurrence after adjusting for other confounders. In multivariate Cox regression, recurrent AIH (as a time-dependent covariate) was significantly associated with graft loss (HR 10.79, 95% CI 5.37-21.66, p <0.001) and death (HR 2.53, 95% CI 1.48-4.33, p = 0.001). Conclusion: Recurrence of AIH following transplant is frequent and is associated with younger age at LT, use of mycophenolate mofetil post-LT, sex mismatch and high IgG pre-LT. We demonstrate an association between disease recurrence and impaired graft and overall survival in patients with AIH, highlighting the importance of ongoing efforts to better characterize, prevent and treat recurrent AIH. Lay summary: Recurrent autoimmune hepatitis following liver transplant is frequent and is associated with some recipient features and the type of immunosuppressive medications use. Recurrent autoimmune hepatitis negatively affects outcomes after liver transplantation. Thus, improved measures are required to prevent and treat this condition. (C) 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

引用

页码：84 / 97

页数：15

共 50 条

[41] Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis
Patidar, Kavish R.
Ortiz, Maria Guarnizo
Slaven, James E.
Nephew, Lauren D.
Gomez, Eduardo Vilar
Kettler, Carla D.
Ghabril, Marwan S.
Desai, Archita P.
Orman, Eric S.
Chalasani, Naga
Gawrieh, Samer
HEPATOLOGY COMMUNICATIONS, 2023, 7 (12)
[42] Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis
Asrani, Sumeet K.
Trotter, James
Lake, Jack
Ahmed, Aijaz
Bonagura, Anthony
Cameron, Andrew
DiMartini, Andrea
Gonzalez, Stevan
Im, Gene
Martin, Paul
Mathurin, Philippe
Mellinger, Jessica
Rice, John P.
Shah, Vijay H.
Terrault, Norah
Wall, Anji
Winder, Scott
Klintmalm, Goran
LIVER TRANSPLANTATION, 2020, 26 (01) : 127 - 140
[43] “Weighing the risk”: Obesity and outcomes following liver transplantation
Trevor W Reichman
George Therapondos
Maria-Stella Serrano
John Seal
Rachel Evers-Meltzer
Humberto Bohorquez
Ari Cohen
Ian Carmody
Emily Ahmed
David Bruce
George E Loss
World Journal of Hepatology, 2015, (11) : 1484 - 1493
[44] Weighing the risk: Obesity and outcomes following liver transplantation
Reichman, Trevor W.
Therapondos, George
Serrano, Maria-Stella
Seal, John
Evers-Meltzer, Rachel
Bohorquez, Humberto
Cohen, Ari
Carmody, Ian
Ahmed, Emily
Bruce, David
Loss, George E.
WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (11) : 1484 - 1493
[45] Chronic Rejection Associated with Antiviral Therapy for Recurrent Hepatitis C after Living-Donor Liver Transplantation
Ueda, Yoshihide
Kaido, Toshimi
Ito, Takashi
Ogawa, Kohei
Yoshizawa, Atsushi
Fujimoto, Yasuhiro
Mori, Akira
Miyagawa-Hayashino, Aya
Haga, Hironori
Marusawa, Hiroyuki
Chiba, Tsutomu
Uemoto, Shinji
TRANSPLANTATION, 2014, 97 (03) : 344 - 350
[46] Increased risk of portal vein thrombosis in patients with autoimmune hepatitis on the liver transplantation waiting list
Ruiz, Pablo
Sastre, Lydia
Crespo, Gonzalo
Blasi, Annabel
Colmenero, Jordi
Carlos Garcia-Valdecasas, Juan
Navasa, Miquel
CLINICAL TRANSPLANTATION, 2017, 31 (07)
[47] Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study
Lindstrom, Lina
Jorgensen, Kristin K.
Boberg, Kirsten M.
Castedal, Maria
Rasmussen, Allan
Rostved, Andreas Arendtsen
Isoniemi, Helena
Bottai, Matteo
Bergquist, Annika
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (03) : 297 - 304
[48] Cardiovascular Risk Factors in Patients Before and After Successful Liver Transplantation
Gojowy, Damian
Urbaniec-Stompor, Joanna
Adamusik, Joanna
Wojcik, Gabriela
Karkoszka, Henryk
Wiecek, Andrzej
Adamczak, Marcin
ANNALS OF TRANSPLANTATION, 2022, 27
[49] Factors associated with progression of the disease before transplantation in patients with autoimmune hepatitis
Milkiewicz, P
Ahmed, M
Hathaway, M
Elias, E
LIVER, 1999, 19 (01): : 50 - 54
[50] Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation
Kohli, Vivek
Singhal, Ashish
Elliott, Lenzi
Jalil, Sajid
TRANSPLANT INTERNATIONAL, 2012, 25 (02) : 192 - 200

← 1 2 3 4 5 →